We investigated the effects of water-soluble low-molecular-weight β-(1,3-1,6) D-glucan isolated from Aureobasidium pullulans 1A1 strain black yeast (LMW-β-glucan) on mast cell-mediated anaphylactic reactions. Although it is known that LMW-β-glucan has anti-tumor, anti-metastatic and anti-stress effects, the roles of LMW-β-glucan in immediate-type allergic reactions have not been fully investigated. We examined whether LMW-β-glucan could inhibit mast cell degranulation and passive cutaneous anaphylaxis (PCA). LMW-β-glucan dose-dependently inhibited the degranulation of both rat basophilic leukemia (RBL-2H3) and cultured mast cells (CMCs) activated by calcium ionophore A23187 or IgE. However, LMW-β-glucan had no cytotoxicity towards RBL-2H3 cells and CMCs. Furthermore, orally administered LMW-β-glucan inhibited the IgE-induced PCA reaction in mice. These results show LMW-β-glucan to be a possible compound for the effective therapeutic treatment of allergic diseases.
β-glucan, mast cell degranulation, passive cutaneous anaphylaxis, anti-allergic effect
NCBI PubMed ID: 22232243Publication DOI: 10.1271/bbb.110536Journal NLM ID: 9205717Publisher: Japan Society for Bioscience, Biotechnology, and Agrochemistry
Correspondence: k-jippou@cs.kinran.ac.jp
Institutions: Department of Food and Nutrition, Faculty of Human Life Sciences, Senri Kinran University, Suita, Japan, Research and Development Department, Daiso Co., Ltd., Amagasaki, Japan
Methods: biological assays, extraction, gel chromatography, cell growth, precipitation, centrifugation, MTT